268 related articles for article (PubMed ID: 37368692)
1. Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review.
Erro R; Picillo M; Pellecchia MT; Barone P
Toxins (Basel); 2023 Jun; 15(6):. PubMed ID: 37368692
[TBL] [Abstract][Full Text] [Related]
2. Anatomy-guided injections of botulinum neurotoxin in neck muscles: how accurate is needle placement?
Kreisler A; Simonin C; Degardin A; Mutez E; Defebvre L
Eur J Neurol; 2020 Nov; 27(11):2142-2146. PubMed ID: 32579789
[TBL] [Abstract][Full Text] [Related]
3. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia.
Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP
Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697
[TBL] [Abstract][Full Text] [Related]
4. British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin.
Marion MH; Humberstone M; Grunewald R; Wimalaratna S
Pract Neurol; 2016 Aug; 16(4):288-95. PubMed ID: 26976927
[TBL] [Abstract][Full Text] [Related]
5. Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance.
Samotus O; Lee J; Jog M
J Neurol; 2018 Jun; 265(6):1269-1278. PubMed ID: 29557988
[TBL] [Abstract][Full Text] [Related]
6. The barriers and facilitators to satisfaction with botulinum neurotoxin treatment in people with cervical dystonia: a systematic review.
Boyce MJ; McCambridge AB; Bradnam LV; Canning CG; Verhagen AP
Neurol Sci; 2022 Aug; 43(8):4663-4670. PubMed ID: 35593979
[TBL] [Abstract][Full Text] [Related]
7. Spectral EMG Changes in Cervical Dystonia Patients and the Influence of Botulinum Toxin Treatment.
Nijmeijer SWR; de Bruijn E; Verhagen R; Forbes PA; Kamphuis DJ; Happee R; Tijssen MAJ; Koelman JHTM
Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28832550
[TBL] [Abstract][Full Text] [Related]
8. Does Ultrasound Guidance Improve the Effectiveness of Neurotoxin Injections in Patients with Cervical Dystonia? (A Prospective, Partially-Blinded, Clinical Study).
Tyślerowicz M; Dulski J; Gawryluk J; Sławek J
Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287943
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type B for cervical dystonia.
Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
[TBL] [Abstract][Full Text] [Related]
10. Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A.
Solish N; Carruthers J; Kaufman J; Rubio RG; Gross TM; Gallagher CJ
Drugs; 2021 Dec; 81(18):2091-2101. PubMed ID: 34787840
[TBL] [Abstract][Full Text] [Related]
11. The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia.
Hefter H; Schomaecker I; Schomaecker M; Rosenthal D; Samadzadeh S
Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357965
[TBL] [Abstract][Full Text] [Related]
12. INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin.
Misra VP; Colosimo C; Charles D; Chung TM; Maisonobe P; Om S;
J Neurol; 2018 Feb; 265(2):402-409. PubMed ID: 29270685
[TBL] [Abstract][Full Text] [Related]
13. Cervical dystonia - improving the effectiveness of botulinum toxin therapy.
Tyślerowicz M; Kiedrzyńska W; Adamkiewicz B; Jost WH; Sławek J
Neurol Neurochir Pol; 2020; 54(3):232-242. PubMed ID: 32285434
[TBL] [Abstract][Full Text] [Related]
14. Does ultrasound-guidance improve the outcome of botulinum toxin injections in cervical dystonia?
Kreisler A; Djelad S; Simonin C; Baille G; Mutez E; Degardin A; Defebvre L; Labreuche J; Cailliau E; Duhamel A
Rev Neurol (Paris); 2022 Jun; 178(6):591-602. PubMed ID: 34916042
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
Pappert EJ; Germanson T;
Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
[TBL] [Abstract][Full Text] [Related]
16. Changes in sensorimotor network activation after botulinum toxin type A injections in patients with cervical dystonia: a functional MRI study.
Nevrlý M; Hluštík P; Hok P; Otruba P; Tüdös Z; Kaňovský P
Exp Brain Res; 2018 Oct; 236(10):2627-2637. PubMed ID: 29971454
[TBL] [Abstract][Full Text] [Related]
17. Targeting pain in the long-term treatment of cervical dystonia with botulinum toxin A.
Marciniec M; Szczepańska-Szerej A; Papuć E; Rejdak K
Int J Neurosci; 2022 Oct; 132(10):1026-1030. PubMed ID: 33295845
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy and safety of botulinum toxin treatment for cervical dystonia: a critical reappraisal.
Marsili L; Bologna M; Jankovic J; Colosimo C
Expert Opin Drug Saf; 2021 Jun; 20(6):695-705. PubMed ID: 33831328
[No Abstract] [Full Text] [Related]
19. Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia.
Comella C; Ferreira JJ; Pain E; Azoulai M; Om S
J Neurol; 2021 Mar; 268(3):903-912. PubMed ID: 32939574
[TBL] [Abstract][Full Text] [Related]
20. Botulinum Toxin Type A Injection for Cervical Dystonia in Adults with Dyskinetic Cerebral Palsy.
Yi YG; Kim K; Yi Y; Choi YA; Leigh JH; Bang MS
Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
